Univest
Univest
  • Markets

Neuland Laboratories (NEULANDLAB) Share Price Rise: Stock Gains 2.69% Today

  • September 8, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Neuland Laboratories Share Price
Neuland Laboratories Ltd. (NEULANDLAB) share price rose to Rs 21,647.95 today, up 2.69% from the previous close. Market cap was Rs 27,047.59 crore.

Neuland Laboratories Share Price stood at Rs 21,647.95 at 1:07 PM IST on 16 November 2026, up Rs 566.25 or 2.69% from the previous close of Rs 21,081.70. The company has a market capitalisation of Rs 27,047.59 crore, according to latest Univest data.

Univest figures confirm the price action, but they do not point to a specific company trigger. What the numbers do show is a stock that opened at Rs 21,024.30, touched a low of Rs 20,999.00 and a high of Rs 21,700.00, and was at Rs 21,647.95 at the time of writing. That makes the Neuland Laboratories share price rise one of the clearer Stocks Rising Today entries to examine on Univest.

Table of Contents

Toggle
  • Neuland Laboratories Share Price Today: Price Action Analysis
  • Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Neuland Laboratories
  • About Neuland Laboratories
  • Frequently Asked Questions
    • What is the Neuland Laboratories Share Price today?
    • Why is the Neuland Laboratories stock rising today?
    • What is the market capitalisation behind the Neuland Laboratories Share Price?
    • What is the P/E Ratio of Neuland Laboratories?
    • What are the ROE and ROCE of Neuland Laboratories?
    • What are the EPS, book value and dividend yield behind the Neuland Laboratories Share Price?
    • How does the Neuland Laboratories Share Price compare with peer valuations?
    • What is the day range of the Neuland Laboratories Share Price Today?
  • Track Neuland Laboratories Share Price on Univest

Neuland Laboratories Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 21,647.95
Previous Close Rs 21,081.7
Today's Move Rs 566.25 (+2.69%)
Open Rs 21,024.3
High Rs 21,700
Low Rs 20,999
Market Capitalisation Rs 27,047.59 crore
Market Cap Category Large Cap

Neuland Laboratories Ltd. (NEULANDLAB) rose to Rs 21,647.95 from the previous close of Rs 21,081.7, a move of Rs 566.25 or 2.69%. The stock opened at Rs 21,024.3, reached a high of Rs 21,700, recorded a low of Rs 20,999.

Neuland Laboratories Share Price Today is Rs 21,647.95, a gain of Rs 566.25 or 2.69% over the previous close of Rs 21,081.70. The stock opened at Rs 21,024.30, touched a low of Rs 20,999.00 and a high of Rs 21,700.00, and last traded at Rs 21,647.95. Market capitalisation stands at Rs 27,047.59 crore.

The day low of Rs 20,999.00 sits Rs 25.30 under the opening price of Rs 21,024.30. From the open, the price has moved Rs 623.65 higher to reach its current level, and it sits Rs 648.95 above the day low.

The gap between the day low and the day high is Rs 701.00, and the last traded price of Rs 21,647.95 sits Rs 52.05 below the day high of Rs 21,700.00. These Neuland Laboratories Stock Performance figures are as of 1:07 PM IST and will change as trading continues, so the Neuland Laboratories Share Price Update below should be read as a snapshot of the afternoon session.

Price action is only one part of the picture, so the next section looks at the fundamentals behind the stock.

Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis

Metric Value
Market Capitalisation Rs 27,047.59 crore
P/E Ratio 59.77x
P/B Ratio 13.33x
ROE 21.43%
ROCE 27.5%
EPS Rs 352.73
Book Value Per Share Rs 1,581.31
Dividend Yield 0.16%

Neuland Laboratories Ltd. (NEULANDLAB) fundamental metrics show P/E 59.77x, P/B 13.33x, ROE 21.43%, ROCE 27.5%. Taken on their own, these numbers offer context rather than a trading signal.

Neuland Laboratories Ltd. has a market capitalisation of Rs 27,047.59 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 59.77x, P/B at 13.33x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.43% and ROCE of 27.5%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 352.73, book value per share of Rs 1,581.31, dividend yield of 0.16%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.93x, median ROE of 10.98%, median ROCE of 12.63%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 59.77x
Benchmark Median P/E 30.93x
Benchmark Average P/E 52.22x
Benchmark P/E Range 2.6x to 1,177x
Company P/B Ratio 13.33x
Benchmark Median P/B 2.9x
Company ROE 21.43%
Benchmark Median ROE 10.98%
Company ROCE 27.5%
Benchmark Median ROCE 12.63%
Company Market Capitalisation Rs 27,047.59 crore
Benchmark Median Market Cap Rs 698.04 crore

Neuland Laboratories Ltd. (NEULANDLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Neuland Laboratories Ltd. (NEULANDLAB) has a P/E ratio of 59.77x, which is above the benchmark median of 30.93x, a difference of +93.24%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Neuland Laboratories Ltd. (NEULANDLAB) has a ROE of 21.43%, which is above the benchmark median of 10.98%, a difference of +95.17%. Neuland Laboratories Ltd. (NEULANDLAB) has a ROCE of 27.5%, which is above the benchmark median of 12.63%, a difference of +117.74%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,51,290.91 41.15 5.05 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 3,05,014.11 90.7 16.95 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,77,333.2 83.49 9.65 26.76 19.27
Laurus Labs Ltd. LAURUSLABS 1,30,755.56 97.59 21.57 18.31 18.2
Zydus Lifesciences Ltd. ZYDUSLIFE 1,18,802.71 28.42 4.27 19.69 21.39

Neuland Laboratories Ltd. (NEULANDLAB) has a P/E ratio of 59.77x compared with the displayed peer median of 83.49x. The comparison is relative and should not be read as a recommendation. Its ROE of 21.43% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 27.5% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 27,047.59 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Neuland Laboratories

Neuland Laboratories is one of the stocks rising today, and these five verified points frame the move without any recommendation.

  • Price action: Rs 21,647.95 against a previous close of Rs 21,081.70, a gain of 2.69%.
  • Day range: an open at Rs 21,024.30, a day low of Rs 20,999.00 and a day high of Rs 21,700.00.
  • Valuation: a P/E of 59.77, against an industry median of 30.93, and a P/B of 13.33 against a median of 2.90.
  • Returns: ROE of 21.43% above the median of 10.98%, and ROCE of 27.50% above the median of 12.63%.
  • Size: a market capitalisation of Rs 27,047.59 crore against an industry median of Rs 698.04 crore.

About Neuland Laboratories

Neuland Laboratories Ltd. trades under the symbol NEULANDLAB and operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry. With a market capitalisation of Rs 27,047.59 crore, it belongs to a same-industry group of 205 companies that includes Sun Pharmaceutical Industries, Divi’s Laboratories and Zydus Lifesciences. Further Company Overview details are available on the Univest stock page, while this article sticks to verified price and ratio figures.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is the Neuland Laboratories Share Price today?

Ans. Neuland Laboratories Share Price was Rs 21,647.95 at 1:07 PM IST on 16 November 2026, up Rs 566.25 or 2.69% from the previous close of Rs 21,081.70. The stock opened at Rs 21,024.30 and has touched a high of Rs 21,700.00.

Why is the Neuland Laboratories stock rising today?

Ans. Univest figures confirm the price action, but they do not point to a specific company trigger. The Neuland Laboratories Share Price rose 2.69% to Rs 21,647.95, and the day range so far runs from Rs 20,999.00 to Rs 21,700.00.

What is the market capitalisation behind the Neuland Laboratories Share Price?

Ans. Neuland Laboratories has a market capitalisation of Rs 27,047.59 crore, according to latest Univest data. Market capitalisation describes company size rather than quality, and it sits above the same-industry median of Rs 698.04 crore across 205 companies.

What is the P/E Ratio of Neuland Laboratories?

Ans. The P/E Ratio of Neuland Laboratories is 59.77, compared with a same-industry median of 30.93 and an average of 52.22. The P/B Ratio is 13.33 against a benchmark median of 2.90, according to the latest Univest figures.

What are the ROE and ROCE of Neuland Laboratories?

Ans. Neuland Laboratories reports ROE of 21.43% and ROCE of 27.50%. The same-industry benchmark medians are 10.98% for ROE and 12.63% for ROCE, so both sit above their reference points, according to latest Univest data.

What are the EPS, book value and dividend yield behind the Neuland Laboratories Share Price?

Ans. EPS is Rs 352.73, book value per share is Rs 1,581.31 and dividend yield is 0.16%. Dividend yield is historical data, not a guide to future payouts, and EPS shows the earnings attributable to each share.

How does the Neuland Laboratories Share Price compare with peer valuations?

Ans. Against Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Laurus Labs and Zydus Lifesciences, Neuland Laboratories has a P/E Ratio of 59.77, above Sun Pharmaceutical Industries and Zydus Lifesciences and below the other three, with a smaller market capitalisation than all five.

What is the day range of the Neuland Laboratories Share Price Today?

Ans. The stock opened at Rs 21,024.30, touched a low of Rs 20,999.00 and a high of Rs 21,700.00. At 1:07 PM IST it last traded at Rs 21,647.95, which is Rs 52.05 below the day high.

Track Neuland Laboratories Share Price on Univest

Use Neuland Laboratories Ltd. (NEULANDLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track the Neuland Laboratories Share Price live on Univest, along with fundamental ratios, 52-week levels and market insights. Univest brings the P/E Ratio, P/B Ratio, ROE and ROCE together on one page, so the Neuland Laboratories Share Price Today can be read against its sector and peers whenever the figures change. Univest also publishes Market Update pages for stocks in the news, with no recommendation attached.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply